1 in 10 patients taking Wegovy and Ozempic lose less than 5 per cent of body weight despite high expectations

An estimated one in 50 UK adults now use fat jabs with demand soaring since 2023 when the National Institute for Health and Care Excellence (Nice) approved Wegovy for weight loss on the NHS.